Aviva PLC Sarepta Therapeutics, Inc. Transaction History

Aviva PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$65.97 - $92.48 $1.61 Million - $2.26 Million	-24,387 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$69.38 - $86.75 $110,244 - $137,845	-1,589 Reduced 6.12%	24,387 $1.9 Million
Q1 2021 May 13, 2021	SELL	$72.25 - $168.95 $613,258 - $1.43 Million	-8,488 Reduced 24.63%	25,976 $1.94 Million
Q4 2020 Feb 10, 2021	SELL	$125.56 - $178.74 $494,831 - $704,414	-3,941 Reduced 10.26%	34,464 $5.88 Million
Q3 2020 Nov 12, 2020	BUY	$127.12 - $172.34 $4.88 Million - $6.62 Million	38,405 New	38,405 $5.39 Million

529

84.1M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $11.1B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

Stay updated on Aviva PLC with notifications on news.